OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection
Beatrice Ondondo, Hayato Murakoshi, Genevieve Clutton, et al.
Molecular Therapy (2016) Vol. 24, Iss. 4, pp. 832-842
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Modified Vaccinia Virus Ankara
Asisa Volz, Gerd Sutter
Advances in virus research (2016), pp. 187-243
Open Access | Times Cited: 278

CD8+ T cells in HIV control, cure and prevention
David R. Collins, Gaurav D. Gaiha, Bruce D. Walker
Nature reviews. Immunology (2020) Vol. 20, Iss. 8, pp. 471-482
Open Access | Times Cited: 241

Latency reversal and viral clearance to cure HIV-1
David M. Margolis, J. Víctor García, Daria J. Hazuda, et al.
Science (2016) Vol. 353, Iss. 6297
Open Access | Times Cited: 221

Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention
Kathryn E. Stephenson, Kshitij Wagh, Bette Korber, et al.
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 673-703
Open Access | Times Cited: 102

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA
Nathifa Moyo, Annette B. Vogel, Søren Buus, et al.
Molecular Therapy — Methods & Clinical Development (2018) Vol. 12, pp. 32-46
Open Access | Times Cited: 85

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)
Beatriz Mothe, Míriam Rosás-Umbert, Pep Coll, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 72

HIV mRNA Vaccines—Progress and Future Paths
Zekun Mu, Barton F. Haynes, Derek W. Cain
Vaccines (2021) Vol. 9, Iss. 2, pp. 134-134
Open Access | Times Cited: 71

Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy
Joanna Warren, Genevieve Clutton, Nilu Goonetilleke
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 68

Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)
Beatriz Mothe, Christian Manzardo, Álvaro Sánchez-Bernabéu, et al.
EClinicalMedicine (2019) Vol. 11, pp. 65-80
Open Access | Times Cited: 57

HIV vaccinology: 2021 update
Jeong Hyun Lee, Shane Crotty
Seminars in Immunology (2021) Vol. 51, pp. 101470-101470
Open Access | Times Cited: 46

Polyvalent vaccine approaches to combat HIV‐1 diversity
Bette Korber, Peter Hraber, Kshitij Wagh, et al.
Immunological Reviews (2017) Vol. 275, Iss. 1, pp. 230-244
Open Access | Times Cited: 55

T cell-based strategies for HIV-1 vaccines
Bette Korber, Will Fischer
Human Vaccines & Immunotherapeutics (2019) Vol. 16, Iss. 3, pp. 713-722
Open Access | Times Cited: 54

Towards the knowledge-based design of universal influenza epitope ensemble vaccines
Qamar M. Sheikh, Derek Gatherer, Pedro A. Reche, et al.
Bioinformatics (2016) Vol. 32, Iss. 21, pp. 3233-3239
Open Access | Times Cited: 42

CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication
Hayato Murakoshi, Chengcheng Zou, Nozomi Kuse, et al.
Retrovirology (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 42

Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine
James Theiler, Hyejin Yoon, Karina Yusim, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 40

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+ T cells in African adults
Gaudensia Mutua, Bashir Farah, Robert Langat, et al.
Molecular Therapy — Methods & Clinical Development (2016) Vol. 3, pp. 16061-16061
Open Access | Times Cited: 39

Applications of cell therapy in the treatment of virus-associated cancers
Keri Toner, Chase D. McCann, Catherine M. Bollard
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 10, pp. 709-724
Closed Access | Times Cited: 4

DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV
Xintao Hu, Antonio Valentin, Frances Dayton, et al.
The Journal of Immunology (2016) Vol. 197, Iss. 10, pp. 3999-4013
Open Access | Times Cited: 37

Role of HIV-specific CD8+ T cells in pediatric HIV cure strategies after widespread early viral escape
Ellen M. Leitman, Christina Thobakgale, Emily Adland, et al.
The Journal of Experimental Medicine (2017) Vol. 214, Iss. 11, pp. 3239-3261
Open Access | Times Cited: 34

Therapeutic Vaccines for the Treatment of HIV
Zhilin Chen, Boris Jülg
Translational research (2020) Vol. 223, pp. 61-75
Open Access | Times Cited: 32

Strategies for inducing effective neutralizing antibody responses against HIV-1
Iván del Moral-Sánchez, Kwinten Sliepen
Expert Review of Vaccines (2019) Vol. 18, Iss. 11, pp. 1127-1143
Open Access | Times Cited: 30

The HIV-1 latent reservoir is largely sensitive to circulating T cells
Joanna Warren, Shuntai Zhou, Yinyan Xu, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 30

Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques
Antonio Valentin, Cristina Bergamaschi, Margherita Rosati, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18

Page 1 - Next Page

Scroll to top